Home > Insider Trading > Filing (0001123292-20-000111)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356090	Intrexon Corp	XON	Services-Commercial Physical & Biological Research (8731)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1583188	D. Thomas Reed	20374 Seneca Meadows Parkway Germantown MD 20876	Chief Science Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-01-04	18,940	$0.00	154,304	No	4	M	Direct
Common Stock	Disposition	2020-01-06	5,416	$5.83	148,888	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-01-04	18,940	$0.00	18,940	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,818			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	62,840	Indirect	By trust
Common Stock	41,705	Indirect	By trust of spouse
Common Stock	2,440	Indirect	By spouse

Footnotes

Each restricted stock unit represents a contingent right to receive one share of XON common stock.
This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
Held by the Thomas David Reed Living Trust dated February 4, 2011.
Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.
The restricted stock units were granted on January 4, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022 and 2023.